Please ensure Javascript is enabled for purposes of website accessibility

Curaleaf Revenue Rises, Net Loss Deepens

By Eric Volkman – Updated Aug 28, 2019 at 4:42PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's busy acquisition strategy has affected profitability.

Coming at the tail end of what can be considered the latest marijuana stock earnings season, Curaleaf (CURLF -2.22%) on Tuesday unveiled its fiscal second-quarter 2019 results.

For the quarter, the company booked total revenue of $48.5 million, a more-than-threefold increase from the Q2 of fiscal 2018. In contrast, its net loss nearly quintupled -- it deepened to $24.5 million ($0.05 per share) from the year-ago shortfall of $4.93 million ($0.01).

Cannabis buds in an overturned glass jar next to a vape pen

Image source: Getty Images

Neither line item met analyst expectations, according to information presented by MarketWatch and The Wall Street Journal. Estimates gathered by FactSet were for $49.8 million in total revenue, according to MarketWatch. (Editor's note: A representative of Curaleaf reached out to The Motley Fool to say that the estimates were for "managed" revenue and the company therefore beat those expectations, reporting managed revenue of $55.1 million. Curaleaf defines managed revenue as "total revenue plus revenue from entities for which the Company has a management contract but does not consolidate the financial results based on IFRS 10 – Consolidated Financial Statements." MarketWatch maintains the estimates are for total revenue.)

Information presented by The Wall Street Journal indicates analysts were expecting a per-share net loss of $0.02. 

A steeper loss was certainly not a surprise. In line with general trends in marijuana stocks, Curaleaf has engaged in a strategy of rapid expansion through acquisitions. In Q2 alone, these included a deal to pay $950 million to buy Cura Partners, maker of the Select brand of premium vaporizer cartridges. The company also struck deals to buy two dispensaries and a cannabis growth/retail operation in Arizona.

After Q2, Curaleaf was and is still actively shopping for assets. Last month, it announced that it signed an agreement to purchase dispensary operator GR Companies (doing business as Grassroots) in an $875 million cash-and-stock transaction. The company claimed the deal "solidifie[d] Curaleaf's position as the world's largest cannabis company by revenue and the largest in the U.S. across key operating metrics." 

This acquisition binge is a key reason for the deepened net loss. The company intends to absorb bottom-line deficits on its way to becoming a major force in the retail segment of the cannabis market.

"We have made significant progress over the last few months in executing on our strategy to become the leading vertically integrated multi-state cannabis operator in the United States," Curaleaf wrote in the press release detailing the Q2 results. "With the industry's largest operational footprint, we have the scale to rapidly accelerate growth across the country."

Going by Curaleaf stock's performance today, it seems investors are generally on board with the company's optimism. The shares closed up marginally higher on the day.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$4.85 (-2.22%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.